News

Boston Scientific will use the new license in ultra-low power integrated circuits for implantable cardiac rhythm management device applications. Sean Redmond, vice president of worldwide field operations at

According to ReGear, the funds will be used to drive growth and further expansion into the global sports medicine, physical medicine, rehabilitation, and chiropractic markets, and develop products

According to Hospira, the majority of reductions will occur in the next 12 months. The company will help prepare employees for the transitions through the provision of assistance

Mr Spencer was CFO of the UK biotechnology Company Antisoma until November 2008, a position he held for 12 years. He qualified as a chartered account with KPMG

Under the terms of the collaboration, University of Texas (UT) Southwestern researchers will conduct preclinical and clinical studies to evaluate the efficacy of Homspera. As part of these

Gilead Sciences, a biotechnology company, has announced that the Committee for Medicinal Products for Human Use, the scientific committee of the European Medicines Agency, has adopted a negative

EPA announced in the Federal Register on March 16 that it will hold a public meeting on Tuesday, March 31 on a test rule proposed under TSCA Section

On March 10, a preliminary ruling by the European Court of Justice would require registration under REACh of reacted monomers in polymers. Juliane Kokott one of the Advocate

“In recent years, life-saving diagnostic lab tests have been developed that can help doctors clarify inconclusive diagnoses and tailor treatments according to individual patient’s DNA and the specific